Equicaine 20 mg Solution is a Health Canada–registered veterinary drug (DIN 01910043) held by Zoetis Canada Inc, containing Mepivacaine Hydrochloride. Health Canada lists its status as Dormant (status date 06 Jul 2026). Nexara Health has matched 87 registrations of Mepivacaine Hydrochloride across 20 other regulated markets.
Health Canada registration
| DIN | 01910043 |
|---|---|
| Brand name | Equicaine |
| Active ingredient | Mepivacaine Hydrochloride |
| Strength | 20 mg |
| Dosage form | Solution |
| Route | Block/Infiltration ; Epidural ; Intra-Articular |
| Company | Zoetis Canada Inc |
| Status | Dormant — 06 Jul 2026 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Status and company history
Changes Health Canada has recorded for this DIN, as observed by Nexara Health's weekly DPD comparison.
| Date | Field | From | To |
|---|---|---|---|
| 2026-09-03 | Status | Marketed | Dormant |
| 2026-09-03 | Status | Marketed | Dormant |
Mepivacaine Hydrochloride registered in other markets
87 registrations of the same molecule in 20 national registries outside Canada (first 69 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Austria | Mepinaest purum 0,5 % Amp. | — | 5St | green box | eEKO (Erstattungskodex) | |
| Austria | Mepinaest purum 1 % Amp. | — | 5St | green box | eEKO (Erstattungskodex) | |
| Austria | Mepinaest purum 2 % Amp. | — | 5St | green box | eEKO (Erstattungskodex) | |
| Bulgaria | Mepidental | Laboratorios Inibsa, S.A.,, | 30 mg/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Bulgaria | Scandonest | Septodont. | 30 mg/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Czech Republic | Scandonest | — | 30MG/ML | Inj Sol | R | SUKL DLP |
| Denmark | Carbocain | Sandoz A/S | 20 mg/ml | injektionsvæske, opløsning | National | Laegemiddelstyrelsen |
| Denmark | Carbocain | Sandoz A/S | 10 mg/ml | injektionsvæske, opløsning | National | Laegemiddelstyrelsen |
| Denmark | Mepiblock Vet. | Dechra Regulatory B.V. | 20 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Mepidental | Laboratorios INIBSA, S.A. | 30 mg/ml | injektionsvæske, opløsning i cylinderampul | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Mepidor Vet. | VetViva Richter GmbH | 20 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Scandonest | Septodont Ou Septodont S.A.S. Ou Specialites Septodont | 30 mg/ml | injektionsvæske, opløsning | MRP | Laegemiddelstyrelsen |
| Greece | Imeros® Inj.sol 3% W/V Bt X 50 Cartridges (5 Pvc/Al Blisters X 10 Cartridges) X 1,7 mL | Ιουλ.& Ειρ. Τσετη Φαρ/Κα Εργαστηρια Αβεε Δ.τ."Intermed Abee" | non-reimbursed | MoH deltio timwn | ||
| Greece | Mepivakate Inj.sol 3%(30mg/mL) Btx50 (Blister 5x10 Carpulesx1,8ml) | Αδηφαρμ Μ.ε.π.ε. | non-reimbursed | MoH deltio timwn | ||
| Greece | SCANDONEST INJ.SOL 3% BTX5BLIST(πλακετες)Χ10CARTR.X1,7ML | Ιωαννης Τσαπραζης Α.ε. Οδοντ.& Ορθοδ/Κων Ειδων Δ.τ.ιωαννης Τ | non-reimbursed | MoH deltio timwn | ||
| Hong Kong | Mepivastesin Inj (Cartridge) 3% | Henry Schein Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Scandonest 3% Plain Inj | Horseley Co Ltd | Registered | DH Drug Office | ||
| Iceland | Mepidor vet. | Vetviva Richter GmbH | 20 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Ireland | Scandonest 3% w/v Solution for Injection | Septodont | Solution for injection | Marketed | HPRA | |
| MA | Scandicaine 2 % Noradrenaline | — | 36 MG | Solution Injectable Pour Usage Dentaire | P | CNOPS liste des medicaments |
| MA | Scandicaine 2 % Speciale | — | 36 MG | Solution Injectable Pour Usage Dentaire | P | CNOPS liste des medicaments |
| MA | Scandicaine 3 % | — | 54 MG | Solution Injectable Pour Usage Dentaire | P | CNOPS liste des medicaments |
| Netherlands | Imeros 3% w/v oplossing voor injectie | Intermed S.A. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | MEPICART 30 mg/ml oplossing voor injectie | Laboratorios Inibsa, S.A. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Mepivacaïne HCl B.Braun 10 mg/ml, oplossing voor injectie | B. Braun Melsungen AG (Melsungen) | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Mepivacaïne HCl B.Braun 20 mg/ml, oplossing voor injectie | B. Braun Melsungen AG (Melsungen) | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Scandonest 3% zonder vasoconstrictor, oplossing voor injectie | Septodont NV-SA | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Poland | Intra-Epicaine | Dechra Regulatory B.V. | 17,42 mg/ ml (co odpowiada 20 mg mepiwakainy chlorowodorku) | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Mepidont 3% | Molteni Dental s.r.l. | 30 mg/ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Mepivastesin | Pierrel S.p.A. | 30 mg/ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Scandivin | Laboratorios Inibsa S.A. | 30 mg/ml | Roztwór do wstrzykiwań we wkładzie | 2028-07-28 | URPL RPL |
| Poland | Scandonest 30 mg/ml | Septodont | 30 mg/ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Romania | MEPIDENTAL 30 mg/ml | — | 30mg/ml | Sol. Inj. | PR | ANMDMR nomenclator |
| Romania | MEPIVACAINA NORMOGEN 30 mg/ml | — | 30mg/ml | Sol. Inj. | PR | ANMDMR nomenclator |
| Romania | MEPIVACAINA NORMOGEN 30 mg/ml | — | 30mg/ml | Sol. Inj. | PR | ANMDMR nomenclator |
| Romania | MEPIVACAINA NORMOGEN 30 mg/ml | — | 30mg/ml | Sol. Inj. | PR | ANMDMR nomenclator |
| Romania | MEPIVASTESIN 30 mg/ml | — | 30mg/ml | Sol. Inj. | PR | ANMDMR nomenclator |
| Romania | Scandonest 3% Plain | — | 3% | Sol. Inj. | PR | ANMDMR nomenclator |
| Romania | Scandonest 3% Plain | — | 3% | Sol. Inj. | PR | ANMDMR nomenclator |
| Saudi Arabia | Isocaine 3 % Cartridge | — | 3 | Inactive | SFDA | |
| Saudi Arabia | Medicaine 3% Cartridge | — | 30 | Inactive | SFDA | |
| Saudi Arabia | Mepecaine 3% Carpule | — | 3 | Inactive | SFDA | |
| Saudi Arabia | Mepicaton 3% Cartridges (1.8)mL | — | 3 | Inactive | SFDA | |
| Saudi Arabia | Seretide Evohaler | — | 250,25 | Active | SFDA | |
| Singapore | Isocaine (Mepivacaine HCl) Injection 3% | N.k. Luck (S) Pte Ltd | 30 mg/mL | Injection | Prescription Only | HSA |
| Singapore | MEPIVASTESIN INJECTION 30 mg/ml | Joyson Pte. Ltd. | 30 mg/ml | Injection | Prescription Only | HSA |
| Singapore | Scandonest Injection 3% (Without Vaso-Constrictor) | N.k. Luck (S) Pte Ltd | 54 mg/1.8 ml | Injection | Prescription Only | HSA |
| South Africa | Carbocaine 3% Dental | Adcock Ingram Limited | 54 mg/1.8ml | Inj | S4 | DoH SEP database |
| South Africa | Scandonest 3 % Plain | Henry Schein Dental Warehouse (Pty) Ltd | 54 mg | Inj | S4 | DoH SEP database |
| Taiwan | Carbocain 0.5% | Welifide Corporation(Welfide Corporation Yoshitomi Factory) | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Carbocain 0.5% | Welifide Corporation(Welfide Corporation Yoshitomi Factory) | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Carbocain 1% | Welifide Corporation(Welfide Corporation Yoshitomi Factory) | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Carbocain 1% | Welifide Corporation(Welfide Corporation Yoshitomi Factory) | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Carbocain 2% | Welifide Corporation(Welfide Corporation Yoshitomi Factory) | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Carbocain 2% | Welifide Corporation(Welfide Corporation Yoshitomi Factory) | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Carbocaine HCl Injection 3% | Sterling Products International Inc. | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Isocaine 3% | 集康國際股份有限公司青埔倉 | 注射劑 | Registered | TFDA | |
| Turkey | Safecaine %3 Enjeksiyonluk Cozelti Iceren Ampul | Vem İlaç San. Ve Ti̇c. Anoni̇m Şi̇rketi̇ | Aktif | TITCK | ||
| United Arab Emirates | Scandonest 3% | SEPTODONT, France, Saint-Maur des Fosses | 3% [30 mg/ml] | Injection | Active | EDE |
| United Kingdom | Mepivacaine 44mg/2.2ml / Adrenaline (base) 22micrograms/2.2ml (1 in 100,000) solution for injection cartridges | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Mepivacaine 66mg/2.2ml solution for injection cartridges | — | 0001 | NHS dm+d VMP | ||
| United States | Carbocaine | Septodont, Inc. | Injection, Solution | listed | FDA NDC | |
| United States | Mepivacaine | Darby Dental Supply, LLC | Injection, Solution | listed | FDA NDC | |
| United States | Mepivacaine | Benco Dental | Injection, Solution | listed | FDA NDC | |
| United States | Mepivacaine | NDC, Inc. | Injection, Solution | listed | FDA NDC | |
| United States | Mepivacaine | Patterson Dental Supply, Inc. | Injection, Solution | listed | FDA NDC | |
| United States | Mepivacaine | Novocol Pharmaceutical of Canada, Inc. | Injection, Solution | listed | FDA NDC | |
| United States | Mepivacaine HCl | Societa Italiana Medicinali Scandicci S.I.M.S., SrL | Powder | FDA NDC | ||
| United States | Mepivacaine Hydrochloride | Siegfried Evionnaz SA | Powder | FDA NDC |
See every manufacturer of Mepivacaine Hydrochloride worldwide →
Regulator price references for Mepivacaine Hydrochloride
Published list or reimbursement prices for Mepivacaine Hydrochloride presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Austria | Mepinaest purum 2 % Amp. | 2pct | 5St | 5.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Mepinaest purum 0,5 % Amp. | 0.5pct | 5St | 5.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Mepinaest purum 1 % Amp. | 1pct | 5St | 5.55 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Greece | SCANDONEST INJ.SOL 3% BTX5BLIST(πλακετες)Χ10CARTR.X1,7ML | 1.7ml+3pct | 19.37 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Mepivakate Inj.sol 3%(30mg/mL) Btx50 (Blister 5x10 Carpulesx1,8ml) | 30mg/1ml | 19.37 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Imeros® Inj.sol 3% W/V Bt X 50 Cartridges (5 Pvc/Al Blisters X 10 Cartridges) X 1,7 mL | 1.7ml+3pct | 19.37 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Iceland | Mepidor vet. | 20mg/1ml | hgl | 6,321.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| MA | Scandicaine 3 % | 54mg | 1 BOITE 50 CARTOUCHE | 215.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Scandicaine 2 % Noradrenaline | 36mg | 1 BOITE 50 CARTOUCHE | 215.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Scandicaine 2 % Speciale | 36mg | 1 BOITE 50 CARTOUCHE | 215.00 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| Saudi Arabia | Zymar 0.3% Ophthalmic Solution | 1.8ml+3pct | 28.35 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Mepecaine 3% Carpule | 3pct | 50.40 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Mepicaton 3% Cartridges (1.8)mL | 3pct | 68.90 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Isocaine 3 % Cartridge | 3pct | 70.70 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Medicaine 3% Cartridge | 3pct | 94.60 SAR | public | SFDA | 2026-09-01 | |
| South Africa | Scandonest 3 % Plain | 54mg | 1.8 | 515.80 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Carbocaine 3% Dental | 54mg/1.8ml | 1.8 | 1,065.92 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| United Arab Emirates | Scandonest 3% | 30mg/1ml | 50's (1.7ml Cartridge x 50) | 110.00 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Equicaine (DIN 01910043) marketed in Canada?
No. Health Canada lists DIN 01910043 as Dormant as of 06 Jul 2026.
Who holds the Canadian licence for this product?
Zoetis Canada Inc is the company of record in the Health Canada Drug Product Database.
Is Mepivacaine Hydrochloride registered outside Canada?
Yes — Nexara Health has matched 87 registrations in 20 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 01910043, status date 2026-07-06; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHS dm+d VMP, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 01910043, status date 2026-07-06; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHS dm+d VMP, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, SFDA.
Health Canada Drug Product Database (DPD), DIN 01910043, status date 2026-07-06; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EU national register, FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NHS dm+d VMP, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.